Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA

From The IMID Forum by The Immune-Mediated Inflammatory Disease Forum

July 16, 2026 · 24 min

About this episode

Dr Sofia Ramiro and Professor Atul Deodhar discuss the long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA.

Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA.

More episodes of The IMID Forum

Author Interview: Dr Murat Torgutalp, June 2026 · July 9, 2026 · 29 min
Discussing RA: Infectious complications of RA treatments · June 25, 2026 · 10 min
Author Interview: Doctor Chung-Mao Kao, May 2026 · June 23, 2026 · 14 min
Discussing PsA: Personalising treatment targets – understanding clinically meaningful improvement · June 18, 2026 · 13 min

Explore listener stats, chart rankings, contacts and more on the The IMID Forum podcast page.